Energy demands from big tech, including for AI, has elected officials giving an old power source a second look. Story from @CalMatters.org.

Alberta’s ambitious plans to see $100 billion worth of artificial intelligence data centre infrastructure built in the province over the next five years are still on track despite a recent development ...

The company reports its latest results Feb. 4, and there are several things investors should assess. Corporate America just kicked off a new quarterly earnings season. Over the next few weeks, ...

AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...

DeepSeek, the Chinese artificial intelligence startup that sent tech stocks reeling this week, sparked fresh concerns about U ...

Anthropic's Dario Amodei explained why the DeepSeek AI isn't that surprising or cheap and how and why the US will reach AGI ...

The result was Athenic AI, a company that uses AI to run data analytics for enterprises across all of their data sources.

DeepSeek claims its R1 outperforms OpenAI’s latest o1 model despite costing a fraction of the price the U.S. AI lab charges for its large language models.

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

Both major and minor players in the sector are leveraging technology to reduce costs, identify and assess new deposits, and ...

SAP said on Tuesday that the prospect of cheaper and more energy-efficient artificial intelligence models, presaged by ...

Nvidia shares' 9% recovery Tuesday was the second-best day in terms of market cap added for any company ever—but the company ...